Hepion Pharmaceuticals Statistics
Total Valuation
HEPA has a market cap or net worth of 697,219. The enterprise value is 618,349.
| Market Cap | 697,219 |
| Enterprise Value | 618,349 |
Important Dates
The next estimated earnings date is Friday, March 27, 2026.
| Earnings Date | Mar 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HEPA has 11.62 million shares outstanding. The number of shares has increased by 7,556.50% in one year.
| Current Share Class | 11.62M |
| Shares Outstanding | 11.62M |
| Shares Change (YoY) | +7,556.50% |
| Shares Change (QoQ) | +0.49% |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | 0.24% |
| Float | 11.62M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 0.26 |
| P/TBV Ratio | 0.72 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.07 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.25, with a Debt / Equity ratio of 0.02.
| Current Ratio | 10.25 |
| Quick Ratio | 6.11 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -154.10 |
Financial Efficiency
Return on equity (ROE) is -2,058.63% and return on invested capital (ROIC) is -125.09%.
| Return on Equity (ROE) | -2,058.63% |
| Return on Assets (ROA) | -100.37% |
| Return on Invested Capital (ROIC) | -125.09% |
| Return on Capital Employed (ROCE) | -135.75% |
| Weighted Average Cost of Capital (WACC) | 16.43% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -4.14M |
| Employee Count | 2 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -92.62% in the last 52 weeks. The beta is 1.94, so HEPA's price volatility has been higher than the market average.
| Beta (5Y) | 1.94 |
| 52-Week Price Change | -92.62% |
| 50-Day Moving Average | 0.05 |
| 200-Day Moving Average | 0.06 |
| Relative Strength Index (RSI) | 55.24 |
| Average Volume (20 Days) | 20,767 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.01 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -3.76M |
| Pretax Income | -8.28M |
| Net Income | -8.28M |
| EBITDA | -3.73M |
| EBIT | -3.76M |
| Earnings Per Share (EPS) | -0.88 |
Balance Sheet
The company has 1.83 million in cash and 54,066 in debt, with a net cash position of 1.77 million or 0.15 per share.
| Cash & Cash Equivalents | 1.83M |
| Total Debt | 54,066 |
| Net Cash | 1.77M |
| Net Cash Per Share | 0.15 |
| Equity (Book Value) | 2.67M |
| Book Value Per Share | 0.08 |
| Working Capital | 2.77M |
Cash Flow
| Operating Cash Flow | -3.27M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 30,758 |
| Net Borrowing | -3.37M |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
HEPA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7,556.50% |
| Shareholder Yield | -7,556.50% |
| Earnings Yield | -1,187.27% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 18, 2025. It was a reverse split with a ratio of 0.02.
| Last Split Date | Mar 18, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.02 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |